{{Rsnum
|rsid=1464500
|Gene=SOX5
|Chromosome=12
|position=24236726
|Orientation=plus
|GMAF=0.1543
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=RP11-778H2.1,SOX5
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 8.9 | 40.2 | 50.9
| HCB | 0.7 | 8.0 | 91.2
| JPT | 0.9 | 7.1 | 92.0
| YRI | 0.0 | 4.1 | 95.9
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.7 | 8.0 | 91.2
| CHD | 0.0 | 7.3 | 92.7
| GIH | 7.9 | 52.5 | 39.6
| LWK | 0.0 | 2.8 | 97.2
| MEX | 10.5 | 38.6 | 50.9
| MKK | 0.0 | 12.3 | 87.7
| TSI | 8.9 | 43.6 | 47.5
| HapMapRevision=28
}}{{PMID|20195266|OA=1
}} gwas, among 738 schizophrenics genotyped for 492K SNPs, this SNP attained a p-val of 1 x 10^-7 for high density lipoprotein (HDL) as a result of [[perphenazine]] use

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}